HEATHER PARTRIDGE: Open Payments
NPI 1972144152 · ATHENS, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$579 in 26 payments from 12 companies in 2025. Trend: 2023 $504 · 2024 $55 · 2025 $579
Food & beverage: $579
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 7 | $202 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $70 |
| AstraZeneca Pharmaceuticals LP | 3 | $62 |
| Lilly USA, LLC | 3 | $50 |
| Esperion Therapeutics, Inc. | 2 | $45 |
| Amgen Inc. | 2 | $33 |
| Abbott Laboratories | 1 | $24 |
| Exact Sciences Corporation | 1 | $21 |
| Corcept Therapeutics | 1 | $21 |
| PFIZER INC. | 1 | $19 |
Products named: Wegovy, Kerendia, MOUNJARO, NEXLETOL, BREZTRI, EVENITY, FARXIGA, FREESTYLE LIBRE 3.
Industry payments across GA — which companies pay providers there.
